advertisement
García-Bardera J 22
Showing records 1 to 22 | Display all abstracts from García-Bardera J127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
García-Bardera J
Ophthalmology. Glaucoma 2025; 8: 495-502
128117 Exposure of PreserFlo Microshunt: Risk Factors and Surgical Management
Morales-Fernández L
Journal of Glaucoma 2025; 34: e65-e68
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
García-Bardera J
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
García-Bardera J
Ophthalmology. Glaucoma 2025; 8: 495-502
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
García-Bardera J
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
García-Bardera J
Ophthalmology. Glaucoma 2025; 8: 495-502
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
García-Bardera J
International Ophthalmology 2025; 45: 286
128117 Exposure of PreserFlo Microshunt: Risk Factors and Surgical Management
García-Bardera J; García-Bardera J
Journal of Glaucoma 2025; 34: e65-e68
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
Garcia-Bermúdez M
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
Garcia-Feijoo J
Ophthalmology. Glaucoma 2025; 8: 495-502
128117 Exposure of PreserFlo Microshunt: Risk Factors and Surgical Management
García-Bardera J
Journal of Glaucoma 2025; 34: e65-e68
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
Robles-Amor P
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
Morales-Fernández L
Ophthalmology. Glaucoma 2025; 8: 495-502
128117 Exposure of PreserFlo Microshunt: Risk Factors and Surgical Management
Martínez-de-la-Casa JM
Journal of Glaucoma 2025; 34: e65-e68
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
Morales-Fernandez L
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
Heredia-Pastor C
Ophthalmology. Glaucoma 2025; 8: 495-502
128117 Exposure of PreserFlo Microshunt: Risk Factors and Surgical Management
García-Feijoo J
Journal of Glaucoma 2025; 34: e65-e68
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
Heredia-Pastor C; Ponce-de-León Á
Ophthalmology. Glaucoma 2025; 8: 495-502
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
Martinez-de-la-Casa JM
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
García-Bermúdez M
Ophthalmology. Glaucoma 2025; 8: 495-502
127456 Clinical use of Ahmed glaucoma valve at a tertiary hospital in Spain (2010-2022) with emphasis on the last 5 years
Garcia-Feijoo J
International Ophthalmology 2025; 45: 286
127432 Outcomes of Preserflo MicroShunt Implantation in Refractory Childhood Glaucoma Following Ahmed Glaucoma Valve Surgery
Pascual-Santiago MA; Burgos-Blasco B; Martínez-de-la-Casa JM; Garcia-Sánchez J
Ophthalmology. Glaucoma 2025; 8: 495-502
